Results 41 to 50 of about 121,404 (231)
Neurological manifestations and neuro-invasive mechanisms of the severe acute respiratory syndrome coronavirus type 2 [PDF]
, 2020 Background and purpose Infections with coronaviruses are not always confined to the respiratory tract and various neurological manifestations have been reported.
Boon, Paul +6 more
core +2 more sources
, 2014 Coronaviruses of humans were first identified more than 60 years ago from individuals with respiratory infections, mainly mild. Two different viruses, 229E and OC43 were initially recognized. Because of difficulty in isolating them using standard techniques, many of the early studies of their occurrence were seroepidemiologic. They were confirmed to be
Monto, Arnold S. +2 more
openaire +1 more source
Vaccine Candidate Against COVID-19 Based on Structurally Modified Plant Virus as an Adjuvant
Frontiers in Microbiology, 2022 A recombinant vaccine candidate has been developed based on the major coronaviruses’ antigen (S protein) fragments and a novel adjuvant—spherical particles (SPs) formed during tobacco mosaic virus thermal remodeling.
Angelina O. Kovalenko +10 more
doaj +1 more source
Porcine innate and adaptative immune responses to influenza and coronavirus infections [PDF]
, 2006 Both innate and adaptative immune responses contribute to the control of infectious diseases, including by limiting the spreading of zoonotic diseases from animal reservoirs to humans.
Asselin-Paturel +35 more
core +2 more sources
Emerging Infectious Diseases, 2021 We reviewed the timeline of key policies for control of the coronavirus disease epidemic and determined their impact on the epidemic and hospital burden in South Korea. Using a discrete stochastic transmission model, we estimated that multilevel policies,
Hae-Young Kim +13 more
doaj +1 more source
Srpski arhiv za celokupno lekarstvo, 1993 Corona viruses belong to a group of not yet well known viruses isolated in patients with infections of the upper respiratory organs, especially in winter months. It is presumed that they provoke about 15% - 20% of all infections. However, in the last years more attention has been paid to the role of human corona viruses in the provocation of sickness ...
N, Kuljić-Kapulica, A, Budisin
openaire +3 more sources
Emerging Infectious Diseases, 2021 Pooled nucleic acid amplification tests for severe acute respiratory syndrome coronavirus 2 could increase availability of testing at decreased cost.
Hannah Wang +10 more
doaj +1 more source
COVID-19 Infection: Implications for Perioperative and Critical Care Physicians. [PDF]
, 2020 Healthcare systems worldwide are responding to Coronavirus Disease 2019 (COVID-19), an emerging infectious syndrome caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) virus. Patients with COVID-19 can progress from asymptomatic or
Greenland, John R +3 more
core
Lineage A betacoronavirus NS2 proteins and the homologous torovirus Berne pp1a carboxy-terminal domain are phosphodiesterases that antagonize activation of RNase L [PDF]
, 2017 Viruses in the family Coronaviridae, within the order Nidovirales, are etiologic agents of a range of human and animal diseases, including both mild and severe respiratory diseases in humans.
Chen, Annie I +9 more
core +2 more sources
, 2022 Abstract This chapter begins by describing older coronaviruses, such as SARS and MERS, followed by the novel coronavirus SARS-CoV-2. Details of Pfizer’s mRNA vaccine are described and viral vector vaccines are also reviewed. This chapter will also discuss two small-molecule antiviral drugs: Gilead’s remdesivir and dexamethasone.
Schoeman, Dewald +2 more
openaire +2 more sources